We also tested these monkeys for changes in tau levels, hippocampal mass, CSF indices including AD biomarkers, MRI/PET indices of cognitive function, and behavioural parameters before and after model construction (Fig. 1A, Table 1). This evidence concerns the gene MAPT and Alzheimer disease.